Regulatory roles of copper metabolism and cuproptosis in human cancers
暂无分享,去创建一个
Yongting Luo | Jiaping Wang | Yuting Ji | Peng An | Junjie Luo | Dekui Jin | Niu Dong | Shuaishuai Zhou | Jiaping Wang | Zhe Wang | Dekui Jin | Niujing Dong | Yuting Ji | Yongting Luo | Junjie Luo | Junjie Luo
[1] Congcong Zhu,et al. A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer , 2022, Frontiers in Immunology.
[2] Yang Luo,et al. Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma , 2022, Frontiers in Immunology.
[3] X. Zu,et al. Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma , 2022, Frontiers in Immunology.
[4] Ninghan Feng,et al. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis , 2022, Frontiers in Pharmacology.
[5] János Tóth,et al. Cuproptosis-related gene index: A predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity , 2022, Frontiers in Immunology.
[6] Z. Huang,et al. Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer , 2022, Frontiers in Genetics.
[7] Yong-chun Li,et al. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas , 2022, Frontiers in Immunology.
[8] Yang Liu,et al. Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer , 2022, Frontiers in Oncology.
[9] Jianhao Zhang,et al. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker , 2022, Frontiers in Genetics.
[10] Mei Li,et al. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer , 2022, Frontiers in Immunology.
[11] Zhen Zhang,et al. Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma , 2022, Frontiers in Immunology.
[12] Jinhua Xu,et al. Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma , 2022, Frontiers in Pharmacology.
[13] Lingmin Xie,et al. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma , 2022, Genes.
[14] R. He,et al. Cuproptosis: copper-induced regulated cell death , 2022, Science China Life Sciences.
[15] T. Golub,et al. Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.
[16] A. Seth,et al. Association of heavy metals and trace elements in renal cell carcinoma: A case-controlled study. , 2021, Urologic oncology.
[17] A. Rahimi,et al. Association between trace elements in cancerous and non-cancerous tissues with the risk of breast cancers in western Iran , 2021, Environmental Science and Pollution Research.
[18] L. Schomburg,et al. Copper Isotopes and Copper to Zinc Ratio as Possible Biomarkers for Thyroid Cancer , 2021, Frontiers in Medicine.
[19] D. Gu,et al. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear‐cell renal cell carcinoma , 2021, FEBS open bio.
[20] F. Giorgi,et al. Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics , 2021, ChemMedChem.
[21] G. Ferns,et al. Lysyl Oxidase Mechanisms to Mediate Gastrointestinal Cancer Progression , 2020, Gastrointestinal Tumors.
[22] M. Petris,et al. Copper metabolism as a unique vulnerability in cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.
[23] Yue Feng,et al. Serum copper and zinc levels in breast cancer: A meta-analysis. , 2020, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[24] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[25] M. Bhatt,et al. Wilson disease. , 2020, Current opinion in neurology.
[26] Ji Chen,et al. The molecular mechanisms of copper metabolism and its roles in human diseases , 2020, Pflügers Archiv - European Journal of Physiology.
[27] Duane D. Winkler,et al. Copper Sources for Sod1 Activation , 2020, Antioxidants.
[28] H. Adly,et al. Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients , 2020, Current Urology.
[29] S. Baldari,et al. Current Biomedical Use of Copper Chelation Therapy , 2020, International journal of molecular sciences.
[30] P. Wittung-Stafshede,et al. Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration , 2020, Proceedings of the National Academy of Sciences.
[31] P. Wittung-Stafshede,et al. Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer , 2020, Breast Cancer.
[32] L. Rossi,et al. Copper homeostasis as target of both consolidated and innovative strategies of anti-tumor therapy. , 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[33] J. Collins,et al. Animal Models of Normal and Disturbed Iron and Copper Metabolism. , 2019, The Journal of nutrition.
[34] Ç. Yenisey,et al. Serum Copper and Zinc Levels in Patients with Endometrial Cancer , 2019, Biological Trace Element Research.
[35] K. Kazan,et al. Ferroptosis: Yet Another Way to Die. , 2019, Trends in plant science.
[36] Zhongguo Zhou,et al. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort , 2019, International journal of cancer.
[37] T. Golub,et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress , 2019, Nature Chemical Biology.
[38] K. Sui,et al. Differential diagnosis of multielements in cancerous and non-cancerous esophageal tissues. , 2019, Talanta.
[39] Shan Zhu,et al. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis , 2019, Proceedings of the National Academy of Sciences.
[40] A. Pai. Iron Oxide Nanoparticle Formulations for Supplementation. , 2019, Metal ions in life sciences.
[41] M. Hou,et al. Oxidative stress-modulating drugs have preferential anticancer effects - involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration. , 2019, Seminars in cancer biology.
[42] R. Weinberg,et al. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature reviews. Molecular cell biology.
[43] Xiaping Zhang,et al. Association between serum copper levels and lung cancer risk: A meta-analysis , 2018, The Journal of international medical research.
[44] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[45] J. Rybakowski,et al. Wilson disease , 2018, Nature Reviews Disease Primers.
[46] P. Siegel,et al. Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations , 2018, Oncogene.
[47] Min Zhang,et al. Association between serum copper levels and cervical cancer risk: a meta-analysis , 2018, Bioscience reports.
[48] D. Denoyer,et al. Copper Complexes in Cancer Therapy. , 2018, Metal ions in life sciences.
[49] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[50] M. Sohrabi,et al. Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues , 2018, Biological Trace Element Research.
[51] M. Sohrabi,et al. Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues , 2017, Biological Trace Element Research.
[52] P. Wittung-Stafshede,et al. Roles of Copper-Binding Proteins in Breast Cancer , 2017, International journal of molecular sciences.
[53] Jin‐Young Jang,et al. Ceruloplasmin as a prognostic marker in patients with bile duct cancer , 2017, Oncotarget.
[54] D. Richardson,et al. Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. , 2016, Metallomics : integrated biometal science.
[55] J. Kładny,et al. Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer , 2015, Cancer research and treatment : official journal of Korean Cancer Association.
[56] S. Shojaei,et al. Serum Copper and Zinc Levels Among Iranian Colorectal Cancer Patients , 2016, Biological Trace Element Research.
[57] Delphine Denoyer,et al. Targeting copper in cancer therapy: 'Copper That Cancer'. , 2015, Metallomics : integrated biometal science.
[58] T. Ganz,et al. Ironing out Ferroportin. , 2015, Cell metabolism.
[59] D. Thiele,et al. Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[60] Jie Cao,et al. The Association Between Serum Levels of Selenium, Copper, and Magnesium with Thyroid Cancer: a Meta-analysis , 2015, Biological Trace Element Research.
[61] V. Pavithra,et al. Serum levels of metal ions in female patients with breast cancer. , 2015, Journal of clinical and diagnostic research : JCDR.
[62] H. Mortazavi,et al. Serum levels of ferritin, copper, and zinc in patients with oral cancer , 2014, Biomedical journal.
[63] J. Seebacher,et al. Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis , 2014, Science Signaling.
[64] Anthony R White,et al. Copper as a key regulator of cell signalling pathways , 2014, Expert Reviews in Molecular Medicine.
[65] T. Lassmann,et al. Ceruloplasmin Is a Novel Adipokine Which Is Overexpressed in Adipose Tissue of Obese Subjects and in Obesity-Associated Cancer Cells , 2014, PloS one.
[66] S. Knapp,et al. Copper is required for oncogenic BRAF signaling and tumorigenesis , 2013, Nature.
[67] P. Devane,et al. A CASE-CONTROLLED STUDY , 2014 .
[68] D. Hanahan,et al. Bioavailable copper modulates oxidative phosphorylation and growth of tumors , 2013, Proceedings of the National Academy of Sciences.
[69] R. Mumper,et al. D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms. , 2013, Cancer letters.
[70] T. Singh,et al. Heavy and Trace Metals in Carcinoma of the Gallbladder , 2013, World Journal of Surgery.
[71] Songming Huang,et al. Zinc and Copper Levels in Bladder Cancer: A Systematic Review and Meta-Analysis , 2013, Biological Trace Element Research.
[72] G. Kaiafa,et al. Copper levels in patients with hematological malignancies. , 2012, European journal of internal medicine.
[73] S. Nikolić-Mandić,et al. Matrix Metalloproteinase-9 and the Cu/Zn Ratio as Ancillary Diagnostic Tools in Distinguishing Between the Classical and Follicular Variants of Papillary Thyroid Carcinoma , 2012, Biological Trace Element Research.
[74] D. Thiele,et al. A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling , 2012, Molecular and Cellular Biology.
[75] F. Dammacco,et al. Targeted therapies in cancer , 2018, Surgery (Oxford).
[76] D. Skrajnowska,et al. Effect of Cu supplementation on genomic instability in chemically-induced mammary carcinogenesis in the rat , 2011, Journal of Biomedical Science.
[77] Y. Haupt,et al. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. , 2011, The Biochemical journal.
[78] S. Kaler,et al. ATP7A-related copper transport diseases—emerging concepts and future trends , 2011, Nature Reviews Neurology.
[79] I. Khan,et al. Abnormal Blood Levels of Trace Elements and Metals, DNA Damage, and Breast Cancer in the State of Kuwait , 2011, Biological Trace Element Research.
[80] C. Marzano,et al. Copper in diseases and treatments, and copper‐based anticancer strategies , 2009, Medicinal research reviews.
[81] D. Winge,et al. Copper metallochaperones. , 2010, Annual review of biochemistry.
[82] A. Compston. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509. , 2009, Brain : a journal of neurology.
[83] I. Sandoval,et al. Molecular mechanisms of copper homeostasis. , 2009, Frontiers in bioscience.
[84] Huiqi Xie,et al. Role of copper in angiogenesis and its medicinal implications. , 2009, Current medicinal chemistry.
[85] R. Mumper,et al. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. , 2009, Cancer treatment reviews.
[86] A. Harris,et al. The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using μSRXRF and μXANES , 2008, Physics in medicine and biology.
[87] M. Ushio-Fukai,et al. Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation* , 2008, Journal of Biological Chemistry.
[88] D. Thiele,et al. Mechanisms for copper acquisition, distribution and regulation. , 2008, Nature chemical biology.
[89] M. Olivares,et al. Ceruloplasmin, an Indicator of Copper Status , 2008, Biological Trace Element Research.
[90] F. Schmidt. Meta-Analysis , 2008 .
[91] R. Vyas,et al. A study of serum zinc, selenium and copper levels in carcinoma of esophagus patients , 2006, Indian Journal of Clinical Biochemistry.
[92] P. Karplus,et al. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. , 2007, Journal of molecular biology.
[93] Svetlana Lutsenko,et al. Function and regulation of human copper-transporting ATPases. , 2007, Physiological reviews.
[94] Bryan F. Shaw,et al. Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein. , 2007, Journal of the American Chemical Society.
[95] F. Sarkar,et al. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. , 2007, Cancer research.
[96] Diane J. Rodi,et al. X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis , 2007, Proceedings of the National Academy of Sciences.
[97] M. Yaman,et al. Distribution of trace metal concentrations in paired cancerous and non-cancerous human stomach tissues. , 2007, World journal of gastroenterology.
[98] Dar-Ren Chen,et al. Serum and tissue trace elements in patients with breast cancer in Taiwan , 2002, Biological Trace Element Research.
[99] E. Shoubridge,et al. The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis. , 2007, Cell metabolism.
[100] I. Bertini,et al. Menkes disease , 2007, Cellular and Molecular Life Sciences.
[101] Q Ping Dou,et al. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. , 2006, Cancer research.
[102] M. Fleming,et al. The Steap proteins are metalloreductases. , 2006, Blood.
[103] M. Yaman,et al. Comparison of trace element concentrations in cancerous and noncancerous human endometrial and ovary tissues , 2006, International Journal of Gynecologic Cancer.
[104] S. Merajver,et al. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.
[105] C. Keen,et al. Copper, oxidative stress, and human health. , 2005, Molecular aspects of medicine.
[106] J. Kaplan,et al. Stable Plasma Membrane Levels of hCTR1 Mediate Cellular Copper Uptake* , 2005, Journal of Biological Chemistry.
[107] D. Winge,et al. Cox17 Is Functional When Tethered to the Mitochondrial Inner Membrane* , 2004, Journal of Biological Chemistry.
[108] S. Lutsenko,et al. A Mutation in the ATP7B Copper Transporter Causes Reduced Dopamine β-Hydroxylase and Norepinephrine in Mouse Adrenal , 2003, Neurochemical Research.
[109] Chris Vulpe,et al. Yeast, a model organism for iron and copper metabolism studies , 2003, Biometals.
[110] Minh N. H. Nguyen,et al. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.
[111] S. Merajver,et al. Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. , 2003, Molecular cancer therapeutics.
[112] S. Merajver,et al. Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model. , 2003, Archives of otolaryngology--head & neck surgery.
[113] C. Keen,et al. Developmental consequences of trace mineral deficiencies in rodents: acute and long-term effects. , 2003, The Journal of nutrition.
[114] C. Kwik-Uribe,et al. Copper-Deficient Rat Embryos Are Characterized by Low Superoxide Dismutase Activity and Elevated Superoxide Anions1 , 2003, Biology of reproduction.
[115] P. Tengvall,et al. IL-1α, IL-1β and TNF-α secretion during in vivo/ex vivo cellular interactions with titanium and copper , 2003 .
[116] P. Tengvall,et al. IL-1alpha, IL-1beta and TNF-alpha secretion during in vivo/ex vivo cellular interactions with titanium and copper. , 2003, Biomaterials.
[117] M. Bonham,et al. The immune system as a physiological indicator of marginal copper status? , 2002, The British journal of nutrition.
[118] T Theophanides,et al. Copper and carcinogenesis. , 2002, Critical reviews in oncology/hematology.
[119] D. Thiele,et al. Biochemical Characterization of the Human Copper Transporter Ctr1* , 2002, The Journal of Biological Chemistry.
[120] J. Gitlin,et al. Ceruloplasmin metabolism and function. , 2002, Annual review of nutrition.
[121] S. Merajver,et al. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. , 2002, Neoplasia.
[122] S. Merajver,et al. Radiotherapy and antiangiogenic TM in lung cancer. , 2002, Neoplasia.
[123] P. Gruss,et al. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[124] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[125] J. Valentine,et al. Yeast Lacking Cu-Zn Superoxide Dismutase Show Altered Iron Homeostasis , 2000, The Journal of Biological Chemistry.
[126] D L Price,et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[127] Brem. Angiogenesis and Cancer Control: From Concept to Therapeutic Trial. , 1999, Cancer control : journal of the Moffitt Cancer Center.
[128] W. Johnson,et al. Copper Deprivation Potentiates Oxidative Stress in HL-60 Cell Mitochondria , 1999 .
[129] P. Lee,et al. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. , 1997, The American journal of gastroenterology.
[130] J. Morrow,et al. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[131] S. Kannan,et al. Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma. , 1997, Journal of experimental & clinical cancer research : CR.
[132] F. Soncin,et al. Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. , 1997, Biochemical and biophysical research communications.
[133] M. Linder,et al. Copper biochemistry and molecular biology. , 1996, The American journal of clinical nutrition.
[134] T. Tomizaki,et al. Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 A , 1995, Science.
[135] I. Bertini,et al. A characterization of copper/zinc superoxide dismutase mutants at position 124. Zinc-deficient proteins. , 1991, European journal of biochemistry.
[136] A. Hilliker,et al. Phenotypic consequences of copper-zinc superoxide dismutase overexpression in Drosophila melanogaster. , 1990, Genome.
[137] S. Naik,et al. Role of ceruloplasmin in inflammation: increased serum ceruloplasmin levels during inflammatory conditions and its possible relationship with anti-inflammatory agents. , 1985, Pharmacological research communications.
[138] I. Fridovich. Superoxide radical: an endogenous toxicant. , 1983, Annual review of pharmacology and toxicology.
[139] O. Rennert,et al. The role of copper in iron metabolism. , 1980, Annals of clinical and laboratory science.
[140] E. Underwood,et al. Changes in activity of the Cu-Zn superoxide dismutase enzyme in tissues of the rat with changes in dietary copper. , 1979, The Journal of nutrition.
[141] R. C. Siegel. Lysyl oxidase. , 1979, International review of connective tissue research.
[142] M. Shifrine,et al. Hypothesis for the mechanism of elevated serum copper in cancer patients. , 1978, Oncology.
[143] J. Menkes. KINKY HAIR DISEASE , 1972, Pediatrics.